(Q36636355)

15 August 2017

1 reference

title

Molecular mechanisms of VEGF-A action during tissue repair (English)

1 reference

15 August 2017

Sabine A Eming

1

1 reference

15 August 2017

Thomas Krieg

series ordinal

2

1 reference

15 August 2017

publication date

1 September 2006

1 reference

The journal of investigative dermatology. Symposium proceedings

15 August 2017

published in

1 reference

15 August 2017

volume

11

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

79-86

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jidsymp.5650016

15 August 2017

exact match

0 references

cites work

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Increased levels of the soluble variant of the vascular endothelial growth factor receptor VEGFR-1 are associated with a poor prognosis in wound healing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Placenta growth factor is induced in human keratinocytes during wound healing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Tumor induction of VEGF promoter activity in stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Vascular Endothelial Growth Factor-Induced Migration of Vascular Smooth Muscle Cells in Vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Generation of a novel proteolysis resistant vascular endothelial growth factor165 variant by a site-directed mutation at the plasmin sensitive cleavage site.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Capillary underperfusion in chronic venous insufficiency: a cause for leg ulceration?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Neuropilin-1 participates in wound angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650016

7 January 2021

10.1038/SJ.JIDSYMP.5650016

Identifiers

DOI

1 reference

15 August 2017

1 reference